"The patients need something," said the company's CEO. A Peninsula biotech ... a venture philanthropy fund started by Lululemon Athletica founder Chip Wilson — to push a next-generation CRISPR ...

SRTX has been attempting to raise fresh financing needed to fund its near-term working capital requirements and stretch its ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...

Under this agreement, SOLVE FSHD will provide strategic funding to support a drug screening initiative led by Transcripta Bio. The project will analyze a broad range of approved and late-stage ...

“We are excited to collaborate with SOLVE FSHD on this important initiative,” said Transcripta Bio CEO Chris Moxham ... and philanthropist, Chip Wilson, widely known as the founder and ...

Lululemon shares are tanking Friday after the company issued soft forward guidance for the year ahead, despite beating ...

Lululemon beat Wall Street expectations for fiscal fourth-quarter earnings and revenue, but issued 2025 guidance that disappointed analysts. On an Thursday earnings call, CEO Calvin McDonald said ...

Athleisure giant Lululemon has listened to customers who have been begging it to change one feature in its bestseller leggings. The company's CEO, Calvin McDonald, said in an earnings call with ...

The economy has come for Lululemon Athletica Inc. While the ... On a call with analysts, chief executive officer Calvin McDonald pointed to a survey showing that concerns about inflation and ...